Crinetics Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CRNX on Nasdaq
Location
10222 Barnes Canyon Road, Bldg. #2, San Diego, CA

Insiders trading volume in the past year

Crinetics Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc 10%+ Owner $200M Apr 18, 2022
Richard Scott Struthers President & CEO, Director $66.2M -$7.9M -10.7% Dec 2, 2024
Ajay Madan Chief Development Officer $7.78M Feb 28, 2022
Wendall Wierenga Director $5.19M Jun 7, 2024
Jeff E. Knight Chief Operating Officer $2.92M -$2.99M -50.6% Nov 22, 2024
Marc Wilson Cfo $1.67M -$5.38M -76.3% Dec 31, 2024
Alan Seth Krasner Chief Medical Officer $1.63M Oct 17, 2023
James Hassard Chief Commercial Officer $1.29M -$1.33M -50.8% Jul 5, 2024
Matthew K. Fust Director $1.04M -$2.65M -71.8% Jun 7, 2024
Coelho Rogerio Vivaldi Director $684K Jun 7, 2024
Dana Pizzuti Chief Med and Dev Officer $624K -$3.95M -86.4% Jan 3, 2025
Stephanie Okey Director $446K -$812K -64.5% Jun 7, 2024
Weston Nichols Director $446K Jun 7, 2024
Caren Deardorf Director $446K Jun 7, 2024
Camille L. Bedrosian Director $446K Jun 7, 2024
Stephen F. Betz Chief Scientific Officer $136K -$1.22M -90% Dec 31, 2024
Isabel Kalofonos Chief Commercial Officer Jan 10, 2025

Recent Insider Transactions by Companies or Individuals for Crinetics Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.